# Biodel

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biodel-2

- Industry: Agribusiness
- Headquarters: Abilene, US
- Website: www.biodelag.com
- Latest round: Series A (Sep 13, 2023)
- Investors on record: 1

## About

Based in Arizona, US, and founded in 2015, Biodel AG operates as a manufacturer of biological solutions for agriculture sectors. In September 2023, the firm raised series A funding led by investor Pangaea Ventures. The firm as of September 2023, has 3 US and 2 International patents on the plant extract discovery, and is led by its CEO and Director, Ben Cloud. Also, the firm has a facility in Maricopa, Arizona with a laboratory, a processing, and a bottling area.

The company provides biological products for crop and livestock production, combating climate change, and improving environmental sustainability in agriculture. One of Biodel’s key products is Cyanoblend™, a blend of Cyanobacteria strains that restores soil health and functionality. This technology has proven effective in reclaiming salt-affected soils, a critical need in agriculture. Additionally, Biodel AG offers Isoprenoid Amino Complex® derived from the guayule shrub, promoting plant vigor and resistance to environmental stress. Another product of the firm is Sequester® Soil Amendment, which combines Cyanoblend™ and Isoprenoid Amino Complex® to revitalize soil health and function, enabling better water retention and improved crop yields. 

The company plans to utilize September 2023 funding to speed up the commercialization of the solution.

## Funding rounds

- Series A, Sep 13, 2023 — Pangaea Ventures

## Investors

- Pangaea Ventures (https://capitalatlas.ai/funds/pangaea-ventures) — Series A